Dimension Therapeutics, Inc. Retained Earnings
Dimension Therapeutics, Inc. had Retained Earnings of -$142.94 million as of 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2017-11-06
- 2017-09-30: Retained Earnings (Accumulated Deficit) -$142.94M.
- 2017-06-30: Retained Earnings (Accumulated Deficit) -$126.00M.
- 2017-03-31: Retained Earnings (Accumulated Deficit) -$113.69M.
- 2016-12-31: Retained Earnings (Accumulated Deficit) -$100.19M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2017-09-30 | -$142.94M 10-Q · filed 2017-11-06 |
| 2017-06-30 | -$126.00M 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$113.69M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$100.19M 10-Q · filed 2017-11-06 |
| 2016-09-30 | -$87.17M 10-Q · filed 2016-11-10 |
| 2016-06-30 | -$72.80M 10-Q · filed 2016-08-11 |
| 2016-03-31 | -$60.71M 10-Q · filed 2016-05-12 |
| 2015-12-31 | -$51.19M 10-K · filed 2017-03-09 |
| 2015-09-30 | -$42.17M 10-Q · filed 2015-12-04 |
| 2014-12-31 | -$16.14M 10-K · filed 2016-03-24 |